The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Crosstalk between cancer cells and bone microenvironment in bone metastasis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
Skeletal complications of malignancy
Coleman, R. E. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1588::aid-cncr9>3.0.co;2-g · Cited by 1,502
Integrin signalling during tumour progression
Guo, W., & Giancotti, F. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1490 · Cited by 1,471
Control of osteoblast function and regulation of bone mass
Harada, S.-I., & Rodan, G. A. (2003) · Nature · doi:10.1038/nature01660 · Cited by 1,444
The clinical course of bone metastases from breast cancer
Coleman, R., & Rubens, R. (1987) · British Journal of Cancer · doi:10.1038/bjc.1987.13 · Cited by 1,084
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., & Aaronson, S. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.4.779 · Cited by 933
Hauschka, P. V., Mavrakos, A. E., Iafrati, M. D., Doleman, S. E., & Klagsbrun, M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67143-1 · Cited by 869
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Self-citationBreast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Pearse, R. N., Sordillo, E. M., Yaccoby, S., Wong, B. R., Liau, D. F., Colman, N., Michaeli, J., Epstein, J., & Choi, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201394498 · Cited by 518
Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., & Slamon, D. J. (2003) · PubMed · Cited by 507
Yoneda, T., Williams, P. J., Hiraga, T., Niewolna, M., & Nishimura, R. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.8.1486 · Cited by 473
Self-citationE-cadherin expression in primary carcinomas of the breast and its distant metastases
Kowalski, P. J., Rubin, M. A., & Kleer, C. G. (2003) · Breast Cancer Research · doi:10.1186/bcr651 · Cited by 414
Critical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 390
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Morony, S., Capparelli, C., Sarosi, I., Lacey, D. L., Dunstan, C. R., & Kostenuik, P. J. (2001) · PubMed · Cited by 291
Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer.
Rudland, P. S., Platt-Higgins, A. M., El‐Tanani, M., Rudland, S. D. S., Barraclough, R., Winstanley, J. H. R., Howitt, R., & West, C. R. (2002) · PubMed · Cited by 276
Okazaki, M., Takeshita, S., Kawai, S., Kikuno, R., Tsujimura, A., Kudo, A., & Amann, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32685-6 · Cited by 275
Nefedova, Y., Landowski, T. H., & Dalton, W. S. (2003) · Leukemia · doi:10.1038/sj.leu.2402924 · Cited by 248
Yoneda, T., Sasaki, A., Dunstan, C., Williams, P. J., Bauss, F., De Clerck, Y. A., & Mundy, G. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119435 · Cited by 247
Self-citationHiraga, T., Williams, P. J., Mundy, G. R., & Yoneda, T. (2001) · PubMed · Cited by 241
Self-citationChoi, S. J., Oba, Y., Gazitt, Y., Alsina, M., Cruz, J., Anderson, J., & Roodman, G. D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13116 · Cited by 231
Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone
Pecheur, I., Peyruchaud, O., Serre, C., Guglielmi, J., Voland, C., Bourre, F., Margue, C., Cohen‐Solal, M., Buffet, A., Kieffer, N., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0911fje · Cited by 223
Doerr, M. E., & Jones, J. I. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.5.2443 · Cited by 216
Sanders, J. L., Chattopadhyay, N., Kifor, O., Yamaguchi, T., Butters, R. R., & Brown, E. M. (2000) · Endocrinology · doi:10.1210/en.141.12.4357 · Cited by 215
Michigami, T., Shimizu, N., Williams, P. J., Niewolna, M., Dallas, S. L., Mundy, G. R., & Yoneda, T. (2000) · Blood · doi:10.1182/blood.v96.5.1953 · Cited by 214
Self-citationMbalaviele, G., Dunstan, C. R., Sasaki, A., Williams, P. J., Mundy, G. R., & Yoneda, T. (1996) · PubMed · Cited by 195
Self-citationMori, Y., Shimizu, N., Dallas, M., Niewolna, M., Story, B., Williams, P. J., Mundy, G. R., & Yoneda, T. (2004) · Blood · doi:10.1182/blood-2004-01-0236 · Cited by 176
Self-citationMyoui, A., Nishimura, R., Williams, P. J., Hiraga, T., Tamura, D., Michigami, T., Mundy, G. R., & Yoneda, T. (2003) · PubMed · Cited by 174
Self-citationYi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Self-citationScanning electron microscopy in bone pathology: review of methods, potential and applications.
BOYDE, A., Maconnachie, E., Reid, S. A., Delling, G., & Mundy, G. R. (1986) · PubMed · Cited by 159
Vargas, S. J., Gillespie, M. T., Powell, G. J., Southby, J., Danks, J. A., Moseley, J. M., & Martin, J. T. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070814 · Cited by 147
Chemotactic responses of tumor cells to products of resorbing bone.
Orr, W., Varani, J., Gondek, M. D., Ward, P. A., & Mundy, G. R. (1979) · Science · doi:10.1126/science.569363 · Cited by 145
Integrin α5β1 Promotes Survival of Growth-Arrested Breast Cancer Cells
Korah, R. M., Boots, M., & Wieder, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3853 · Cited by 131
Bisphosphonates as Anticancer Drugs
Mundy, G. R., & Yoneda, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808063390609 · Cited by 126
Self-citationRuoslahti, E. (1996) · Scientific American · doi:10.1038/scientificamerican0996-72 · Cited by 121
Osteopontin Deficiency Reduces Experimental Tumor Cell Metastasis to Bone and Soft Tissues
Nemoto, H., Rittling, S. R., Yoshitake, H., et al. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.4.652 · Cited by 111
A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis
Harms, J. F., Welch, D. R., Samant, R. S., Shevde, L. A., Miele, M. E., Babu, G. R., Goldberg, S. F., Gilman, V. R., Sosnowski, D. M., Campo, D. A., et al. (2004) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000024763.69809.64 · Cited by 109
Nakai, M., Mundy, G. R., Williams, P. J., et al. (1992) · PubMed · Cited by 105
Bone Sialoprotein, Matrix Metalloproteinase 2, and v 3 Integrin in Osteotropic Cancer Cell Invasion
Karadağ, A., Ogbureke, K. U. E., Fedarko, N. S., & Fisher, L. W. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh169 · Cited by 104
Michigami, T., Ihara-Watanabe, M., Yamazaki, M., & Ozono, K. (2001) · PubMed · Cited by 96
Human Bone Marrow Stromal Cells Protect Prostate Cancer Cells From TRAIL-Induced Apoptosis
Nyambo, R., Cross, N. A., Down, J. M., Holen, I., Bryden, G., Hamdy, F. C., & Eaton, C. L. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040703 · Cited by 65
Adwan, H., Bäuerle, T., & Berger, M. R. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700659 · Cited by 61
Kohno, N., Kitazawa, S., Fukase, M., Sakoda, Y., Kanbara, Y., Furuya, Y., Ohashi, O., ISHIKAWA, Y., & Saitoh, Y. (1994) · Surgery Today · doi:10.1007/bf02032890 · Cited by 59
NPT2a — The Key to Phosphate Homeostasis
Kronenberg, H. M. (2002) · New England Journal of Medicine · doi:10.1056/nejme020098 · Cited by 50
Bone remodeling in pathologic conditions
Sela, J. (1977) · Calcified Tissue International · doi:10.1007/bf02012790 · Cited by 38
Laminin 5 β3 and γ 2 chains are frequently coexpressed in cancer cells
Akimoto, S., Nakanishi, Y., Sakamoto, M., Kanai, Y., & Hirohashi, S. (2004) · Pathology International · doi:10.1111/j.1440-1827.2004.01681.x · Cited by 30
Monitoring of skeletal progression of prostate cancer by GFP imaging, X‐ray, and serum OPG and PTHrP
Burton, D. W., Geller, J., Yang, M., Jiang, P. X., Barken, I., Hastings, R. H., Hoffman, R. M., & Deftos, L. J. (2004) · The Prostate · doi:10.1002/pros.20146 · Cited by 30
Cited by
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Langley, R. R., & Fidler, I. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26031 · Cited by 958
Fos/AP‐1 proteins in bone and the immune system
Wagner, E. F., & Eferl, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00332.x · Cited by 537
Molecular Biology of Bone Metastasis
Kingsley, L. A., Fournier, P. G. J., Chirgwin, J. M., & Guise, T. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0234 · Cited by 435
Interleukin-6 in bone metastasis and cancer progression
Ara, T., & DeClerck, Y. A. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.026 · Cited by 379
Metadata
- Authors
- Yoneda, T., & Hiraga, T.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 328
- Issue
- 3
- Pages
- 679-687
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2090589680
- Cited by
- 308
- References
- 59
- FWCI
- 6.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.